E2 ModeratePreliminaryPEM ?ObservationalPeer-reviewedMachine draft
Pressure Point Thresholds and ME/CFS Comorbidity as Indicators of Patient's Response to Manual Physiotherapy in Fibromyalgia.
Falaguera-Vera, Francisco Javier, Garcia-Escudero, María, Bonastre-Férez, Javier et al. · International journal of environmental research and public health · 2020 · DOI
Quick Summary
This study tested whether hands-on physiotherapy (manual therapy) could help people with fibromyalgia (FM) by reducing pain sensitivity and improving quality of life. Researchers measured pain sensitivity before and after treatment using a special device called an algometer. The main finding was that people with fibromyalgia alone responded better to the therapy than those who had both fibromyalgia and ME/CFS.
Why It Matters
This research is important for ME/CFS patients because it identifies that the presence of ME/CFS alongside fibromyalgia may predict poorer responses to manual physiotherapy—information that could help clinicians set realistic expectations and tailor treatment plans. Understanding why ME/CFS comorbidity affects treatment response could also reveal shared biological mechanisms between these overlapping conditions.
Observed Findings
- Patients with lower baseline pain sensitivity (higher algometer thresholds) showed better treatment response to the manual therapy protocol.
- Patients with fibromyalgia alone responded better to the therapy than patients with both fibromyalgia and comorbid ME/CFS.
- The intervention appeared to improve FM hyperalgesia/allodynia and quality of life measures in responders.
- Baseline pressure point thresholds inversely correlated with treatment outcome.
- ME/CFS comorbidity emerged as an unexpected negative predictor of physiotherapy response in post-stratification analysis.
Inferred Conclusions
- Baseline pain sensitivity (measured by PPT) and ME/CFS comorbidity status may serve as predictive indicators of whether a patient will respond to mechanical trigger-based manual physiotherapy.
- Current drug-based treatments for FM have limitations, and physiotherapy could be a useful adjunctive or alternative approach—but only for specific patient subgroups.
- Differential treatment responses between FM and FM+ME/CFS cohorts suggest distinct or at least divergent pathophysiological mechanisms between these conditions.
- Gene expression profiling may reveal molecular mechanisms underlying differential treatment responsiveness.
Remaining Questions
What This Study Does Not Prove
This study does not prove that manual physiotherapy is ineffective for ME/CFS patients, only that this particular protocol showed reduced efficacy in the comorbid subgroup compared to FM-only patients. The observational design without a randomized control group cannot establish causation or rule out confounding variables (such as disease severity differences). Negative findings in one small patient cohort do not preclude benefits from other physiotherapy approaches or in other populations.
Tags
Symptom:PainFatigue
Biomarker:Gene Expression
Phenotype:Gradual Onset
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory OnlyMixed Cohort
Metadata
- DOI
- 10.3390/ijerph17218044
- PMID
- 33142896
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026